Clinical trials
Phase 1/2 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2018 | 3 |
| 2019 | 3 |
| 2021 | 2 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 6 |
| Active, not recruiting | 5 |
| Terminated | 4 |
| Unknown status | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 3 |
| Princess Maxima Center for Pediatric Oncology | 3 |
| Celgene | 2 |
| Novartis Pharmaceuticals | 2 |
| AbbVie | 1 |
| Amgen | 1 |
| Amgen Research (Munich) GmbH | 1 |
| AstraZeneca | 1 |
| Gilead Sciences | 1 |
| Goethe University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 25 |
| Leukemia, Myeloid, Acute | 10 |
| Leukemia | 9 |
| Recurrence | 8 |
| Lymphoma, Non-Hodgkin | 5 |
| Burkitt Lymphoma | 4 |
| Hodgkin Disease | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 4 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.